SEC Form 4 · accession 0001000229-15-000013
CORE LABORATORIES N V · CLB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard L Bergmark
Officer — EVP & CFO · Director
Period of report
Dec 31, 2014
Accepted (ET)
Jan 2, 2015 · 4:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001000229
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | Dec 31, 2014 | M | 12,587 | $0.00 | A | 66,670 | D | |
| Common Shares | Dec 31, 2014 | F | 4,735 | $0.00 | D | 61,935 | D | |
| Common Shares | holding | — | — | — | 69,802 | I | 401(k) Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Performance SharesF1 | $0.00 | Dec 31, 2014 | M | 12,587 | D | — | — | Common Shares | 12,587 | 0 | D |
Explanation of responses
- F1The shares vesting were awarded as restricted performance shares in February 2012. As reported in the Form 4 filing on February 17, 2012 at the time the award was made, "The Restricted Performance Shares vest based on the Company's return on invested capital for the period that began on January 1, 2012 and ends on December 31, 2014 (the "performance period") as follows. If the Company's return on invested capital at the end of the performance period is in the top decile of the return on invested capital of the Company's peers as published by Bloomberg, then the Restricted Performance Shares will fully vest. If this criteria is not met, then no shares shall vest and the award will be forfeited." The performance criteria and all requirements for vesting have been met and thus the shares fully vested on December 31, 2014, at the conclusion of the performance period.